Więckiewicz G

Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Tarnowskie Góry, Poland.

8 papers · ORCID

ArticlePsilocybin

PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.

Marek J, Domek-Gumprecht M, Macionga A +2

Europe PMC2025
ArticlePsilocybin

Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.

Szafoni S, Gręblowski P, Grabowska K +1

Europe PMC2024
ArticleKetamine

Ketamine in Substance Use Disorder Treatment: A Narrative Review.

Famuła A, Radoszewski J, Czerwiec T +2

Europe PMC2024
ArticleMDMA

Intensity of Psychoactive Substance Use Affects the Occurrence of Prodromal Symptoms of Psychosis.

Więckiewicz G, Florczyk I, Stokłosa M +4

Europe PMC2024
ArticlePsilocybin

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study.

Więckiewicz G, Stokłosa I, Stokłosa M +3

Europe PMC2023
ArticlePsilocybin

The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey.

Więckiewicz G, Marek J, Stokłosa I +7

Europe PMC2023
ArticlePsilocybin

Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.

Stokłosa I, Więckiewicz G, Stokłosa M +3

Europe PMC2023
ArticlePsilocybin

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.

Więckiewicz G, Stokłosa I, Piegza M +2

Europe PMC2021